Growth retardation in patients with juvenile idiopathic arthritis and growth hormone therapy
نویسندگان
چکیده
منابع مشابه
Growth retardation in patients with juvenile idiopathic arthritis and growth hormone therapy
Methods Study cohort was presented by 170 JIA patients (47 boys, 123 girls, mean age 12.1, disease duration 5.1 yrs). Annual growth parameters were studied in relation with premorbid and disease related factors. 30 prepubertal patients, having the most significant delay of growing were randomized in 2 groups. 15 patients were received recombinant GH 0,05–0,07 mg/kg within 4–18 months; other 15 ...
متن کاملGrowth Assessment and Vitamin D Level in Egyptian Juvenile Idiopathic Arthritis Patients
Background Juvenile idiopathic arthritis (JIA) is one of the most common rheumatic diseases in childhood and is frequently associated with growth retardation. Vitamin D is critical to bone mineral metabolism and to the growth and development of the skeleton. We aimed to...
متن کاملGrowth retardation and delayed puberty in children and adolescents with juvenile idiopathic arthritis
Juvenile idiopathic arthritis (JIA) is the most common joint disorder in developing children. Juvenile idiopathic arthritis is difficult to diagnose and treat. In some patients, signs and symptoms can be frustratingly inconsistent, contradictory or idiosyncratic. Short stature in patients with JIA is usually due to reduced growth in the lower extremities, and only rarely due to reduced growth i...
متن کاملClinical and Serological Findings in Juvenile Patients with Idiopathic Arthritis in Southwestern of Iran
Introduction: The purpose of this study was to describe clinical features and serological findings of children with idiopathic arthritis in south-western Iran.Methods: This descriptive study included 60 patients with juvenile idiopathic arthritis who were referred to a pediatric rheumatology clinic at a university hospital during 6-month period. Initial manifestations, first laboratory tests an...
متن کاملComparison of Growth Hormone Treatment in Patients with Idiopathic Short Stature and Idiopathic Growth Hormone Deficiency
After recombinant human growth hormone (rhGH) was introduced in the treatment of patients with growth hormone deficiency (GHD) and idiopathic short stature (ISS), many studies have addressed the effect of GH treatment and changes in the height standard deviation score (SDS) after GH treatment. However, few studies comparing the effect of GH in Korean patients with idiopathic GHD and ISS have be...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pediatric Rheumatology
سال: 2008
ISSN: 1546-0096
DOI: 10.1186/1546-0096-6-s1-p50